We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
National Bank Holdings
NBHC
$1.89B
| $1.92M | ﹤0.01% |
51,833
-1,059
| -2% | -$42.5K |
|
452
UBS Group
UBS
$172B
| $1.89M | ﹤0.01% |
130,214
-44,127
| -25% | -$706K |
|
453
Barrett Business Services
BBSI
$995M
| $1.88M | ﹤0.01% |
96,232
+1,920
| +2% | +$38.4K |
|
|
UMH
454
UMH Properties
UMH
$1.32B
| $1.85M | ﹤0.01% |
114,285
+1,222
| +1% | +$22.9K |
|
455
Pure Cycle
PCYO
$260M
| $1.84M | ﹤0.01% |
220,511
-7,106
| -3% | -$72.9K |
|
|
CPRX
456
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.81M | ﹤0.01% |
141,379
+2,821
| +2% | +$33.4K |
|
|
PFC
457
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.81M | ﹤0.01% |
70,496
-1,761
| -2% | -$47.6K |
|
|
HSII
458
DELISTED
Heidrick & Struggles
HSII
| $1.8M | ﹤0.01% |
69,314
-1,526
| -2% | -$45.1K |
|
459
Stryker
SYK
$129B
| $1.76M | ﹤0.01% |
8,692
-5,108
| -37% | -$1.07M |
|
460
Goodyear
GT
$2.04B
| $1.75M | ﹤0.01% |
173,952
-5,096
| -3% | -$64.8K |
|
461
Adecoagro
AGRO
$1.48B
| $1.75M | ﹤0.01% |
210,581
+147,807
| +235% | +$1.24M |
|
462
S&P Global
SPGI
$130B
| $1.73M | ﹤0.01% |
5,659
-2,204
| -28% | -$789K |
|
463
Host Hotels & Resorts
HST
$17.1B
| $1.72M | ﹤0.01% |
108,226
-12,756
| -11% | -$222K |
|
464
FirstCash
FCFS
$9.06B
| $1.67M | ﹤0.01% |
19,814
+9,014
| +83% | +$672K |
|
465
Progressive
PGR
$125B
| $1.67M | ﹤0.01% |
14,329
-347
| -2% | -$41.8K |
|
466
Abbott
ABT
$182B
| $1.66M | ﹤0.01% |
17,134
-3,144
| -16% | -$335K |
|
467
Ezcorp Inc
EZPW
$1.87B
| $1.65M | ﹤0.01% |
213,689
+11,993
| +6% | +$99.4K |
|
468
Sight Sciences
SGHT
$279M
| $1.61M | ﹤0.01% |
252,876
+116,722
| +86% | +$987K |
|
469
Matrix Service
MTRX
$347M
| $1.55M | ﹤0.01% |
373,638
-25,884
| -6% | -$133K |
|
|
FRGI
470
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.55M | ﹤0.01% |
+243,807
| New | +$1.75M |
|
471
BGC Group
BGC
$5.65B
| $1.54M | ﹤0.01% |
489,860
+52,358
| +12% | +$203K |
|
|
DBD
472
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.49M | ﹤0.01% |
609,887
+399,255
| +190% | +$1.33M |
|
473
Argan
AGX
$7.61B
| $1.47M | ﹤0.01% |
45,779
-2,715
| -6% | -$95.7K |
|
474
Brixmor Property Group
BRX
$9.93B
| $1.44M | ﹤0.01% |
78,016
-2,383
| -3% | -$51.5K |
|
475
Builders FirstSource
BLDR
$7.82B
| $1.39M | ﹤0.01% |
25,117
+471
| +2% | +$29.4K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.